Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CI 949

Known as: CI-949 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The allergic mediator release inhibitor CI-949 [5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H-indole-2-carboxamide… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1993
1993
The toxicity of CI-949, an effective inhibitor of allergic mediator release in pharmacology models, was evaluated in rodents and… Expand
Is this relevant?
1991
1991
The allergic mediator release inhibitor Cl-949 [5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H -indole-2-carboxamide… Expand
Is this relevant?
1991
1991
CI-949 is an orally effective inhibitor of allergic mediator release as measured with in vitro and animal models. To assess the… Expand
Is this relevant?
1991
1991
The effect of CI-949, a novel inhibitor of allergic mediator release, on immune function was assessed with holistic mouse models… Expand
Is this relevant?
1990
1990
The novel antiallergy compound, 5-methoxy-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H- indole-2- carboxamide, L-arginine… Expand
Is this relevant?
1989
1989
The immunotoxic properties of two experimental antiallergic drugs, CI-949 and CI-959, were investigated. Wistar rats were gavaged… Expand
Is this relevant?
1987
1987
CI-949 [5-methyl-3-(1-methylethoxy)-1-phenyl-N-1H-tetrazol-5-yl-1H- indole-2- carboxamide, L-arginine salt] inhibits human… Expand
Is this relevant?